SCHEMBL6250239

SCHEMBL6250239

CCCCCCCCCC(=O)Br

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 4/20 0.62
CES1 P23141 4/20 0.62
GPR84 Q9NQS5 7/20 0.59
PPARG P37231 7/20 0.59
PPARD Q03181 7/20 0.59
PPARA Q07869 7/20 0.59
HDAC11 Q96DB2 5/20 0.59
TSHR P16473 5/20 0.59
PTPN1 P18031 3/20 0.59
ALDH1A1 P00352 3/20 0.59
TLR2 O60603 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
FABP4 P15090 2/20 0.59
SLC22A6 Q4U2R8 1/20 0.59
SLC22A8 Q8TCC7 1/20 0.59
MEN1 O00255 1/20 0.59
ESR1 P03372 1/20 0.59
ALOX15 P16050 1/20 0.59
PDE4A P27815 1/20 0.59
KMT2A Q03164 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11593048 1.00 CES2 (0.62) CES2CES1GPR84PPARGPPARD
SCHEMBL6113345 1.00
SCHEMBL3624489 1.00 CES2 (0.62) CES2CES1GPR84PPARGPPARD
SCHEMBL3888466 1.00 CES2 (0.62) CES2CES1GPR84PPARGPPARD
SCHEMBL1716125 1.00 CES2 (0.62) CES2CES1GPR84PPARGPPARD
SCHEMBL10886291 1.00 CES2 (0.62) CES2CES1GPR84PPARGPPARD
SCHEMBL6912045 1.00 CES2 (0.62) CES2CES1GPR84PPARGPPARD
SCHEMBL963716 1.00 CES2 (0.62) CES2CES1GPR84PPARGPPARD
SCHEMBL16777361 1.00 CES2 (0.62) CES2CES1GPR84PPARGPPARD
SCHEMBL4120687 1.00 CES2 (0.62) CES2CES1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119192600-A Hyperbranched neutral polymer bonding agent and preparation method and application thereof 湖北航天化学技术研究所 2024-12-27 CN disclosed
CN-113024359-B Process for preparing alkoxymethyl alkynyl ether compounds having terminal triple bonds 信越化学工业株式会社 2024-06-11 CN disclosed
EP-3842406-B1 PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND SHINETSU CHEMICAL CO (JP) 2023-10-11 EP disclosed
US-11384041-B2 Process for preparing an alkoxymethyl alkynyl ether compound having a terminal triple bond SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-07-12 US disclosed
US-20210198172-A1 PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-07-01 US disclosed
EP-3842406-A1 PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND Shin-Etsu Chemical Co., Ltd. (JP) 2021-06-30 EP disclosed
CN-113024359-A Method for producing alkoxymethyl alkynyl ether compounds having terminal triple bond 信越化学工业株式会社 2021-06-25 CN disclosed
WO-2019189444-A1 LIQUID-CRYSTAL MATERIAL, LIQUID-CRYSTAL FILM, METHOD FOR PRODUCING SAME, SENSOR, AND OPTICAL ELEMENT 学校法人東京理科大学 2019-10-03 WO disclosed
US-20150171395-A1 MODIFIED-CELLULOSE-NANOFIBER CONTAINING POLYETHYLENE FINE POROUS FILM, SEPARATOR, AND LITHIUM-ION BATTERY INCLUDING THE SAME DAINIPPON INK & CHEMICALS (JP) 2015-06-18 US disclosed
EP-0914835-B1 Biocompatible polymeric coatings ALOMONE LABS LTD (IL) 2005-08-24 EP disclosed
US-4898655-A Method for racemization of optically active chrysanthemic acid or its derivatives SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1990-02-06 US disclosed
US-4820864-A Method for racemization of optically active chrysanthemic acid or its ester SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1989-04-11 US disclosed
US-4812264-A Method for racemization of optically active chrysanthemic acid derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1989-03-14 US disclosed
EP-0299760-A1 Method for racemization of optically active chrysanthemic acid or its derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1989-01-18 EP disclosed
EP-0289324-A1 Method for racemization of optically active chrysanthemic acid derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-11-02 EP disclosed
EP-0282221-A2 Method for racemization of optically active chrysanthemic acid or its ester SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-09-14 EP disclosed
US-4698187-A Preparation of carboxylic acid anhydrides THE HALCON SD GROUP, INC. (US) 1987-10-06 US disclosed
US-4559183-A Preparation of carboxylic acid anhydrides THE HALCON SD GROUP, INC. (US) 1985-12-17 US disclosed
US-4044002-A ACYL BROMIDES AND A BROMINE SCAVENGER ELI LILLY AND COMPANY (US) 1977-08-23 US disclosed
US-3946054-A PERFUMES, TOBACCO, FOOD FLAVORS INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1976-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210198172-A1 PROCESS FOR PREPARING AN ALKOXYMETHYL ALKYNYL ETHER COMPOUND HAVING A TERMINAL TRIPLE BOND CBR3, CBR1, AOC2 CES2 212/4885CES1 1397/4885GPR84 3487/4885
US-11384041-B2 Process for preparing an alkoxymethyl alkynyl ether compound having a terminal triple bond CBR3, CBR1, AOC2 CES2 212/4885CES1 1397/4885GPR84 3487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.